IMMUNOLIGHT

Serial Number 97976327
Registration 7197942
700

Registration Progress

Application Filed
Aug 26, 2022
Under Examination
Apr 11, 2023
Approved for Publication
Feb 14, 2023
Published for Opposition
Feb 14, 2023
Registered
Oct 17, 2023

Trademark Image

IMMUNOLIGHT

Basic Information

Serial Number
97976327
Registration Number
7197942
Filing Date
August 26, 2022
Registration Date
October 17, 2023
Published for Opposition
February 14, 2023
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 17, 2023
Registration
Registered
Classes
005

Rights Holder

IMMUNOLIGHT, LLC

16
Address
1901 St. Antoine Street, 6th Floor
1901 St. Antoine Street, 6th Floor
Detroit, MI 48226

Ownership History

IMMUNOLIGHT, LLC

Original Applicant
16
Detroit, MI

IMMUNOLIGHT, LLC

Owner at Publication
16
Detroit, MI

IMMUNOLIGHT, LLC

Original Registrant
16
Detroit, MI

Legal Representation

Attorney
Heather M. Barnes

USPTO Deadlines

Next Deadline
1556 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-10-17)
Due Date
October 17, 2029
Grace Period Ends
April 17, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

34 events
Date Code Type Description
Oct 17, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER
Oct 17, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 13, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 12, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 25, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 24, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 24, 2023 DPCC D DIVISIONAL PROCESSING COMPLETE
Aug 24, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Aug 3, 2023 EISU I TEAS STATEMENT OF USE RECEIVED
Aug 3, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 3, 2023 ERTD I TEAS REQUEST TO DIVIDE RECEIVED
Aug 3, 2023 DRRR I DIVISIONAL REQUEST RECEIVED
Aug 3, 2023 EXT1 S SOU EXTENSION 1 FILED
Aug 3, 2023 EX1G S SOU EXTENSION 1 GRANTED
Aug 3, 2023 IUAF S USE AMENDMENT FILED
Apr 11, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 14, 2023 PUBO A PUBLISHED FOR OPPOSITION
Feb 14, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 25, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 11, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 10, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 10, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 10, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 27, 2022 DOCK D ASSIGNED TO EXAMINER
Dec 27, 2022 CNRT R NON-FINAL ACTION WRITTEN
Dec 27, 2022 GNRT F NON-FINAL ACTION E-MAILED
Dec 27, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 2, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 2, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 2, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 2, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 2, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 14, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cancer
First Use Anywhere: May 31, 2022
First Use in Commerce: May 31, 2022

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...